Breaking Down Merit Medical Systems: 4 Analysts Share Their Views
Portfolio Pulse from Benzinga Insights
Merit Medical Systems (NASDAQ:MMSI) received varied analyst ratings in the last quarter, with an average 12-month price target of $93.00, up from the previous $88.75. Analysts from Piper Sandler, Canaccord Genuity, Barrington Research, and Needham have adjusted their price targets and ratings, reflecting changes in market conditions and company performance. Merit Medical Systems, a medical equipment company, shows strong financial health with a positive revenue trend, high net margin, and efficient debt management, despite lagging behind industry peers in revenue growth.
January 12, 2024 | 4:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Merit Medical Systems has an updated average 12-month price target of $93.00, reflecting a positive sentiment from analysts. The company's strong financial health and positive revenue trend may contribute to investor confidence.
The increase in the average price target to $93.00 suggests that analysts see potential in Merit Medical Systems, likely due to its strong financial indicators such as high net margin and ROE. The positive adjustments in analyst ratings and price targets can lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100